Skip to main content
AmigoFish

ASH 2025 LBA BRUIN-CLL 313 Update: Pirtobrutinib vs Bendamustine/Rituximab in 1L CLL

From Two Onc Docs · · 11 min

This plays from the publisher's own server. We do not host a copy.

Open at the source

Not rated yet

Description

This week’s episode will be focusing on an update of a late-breaking abstract presented at ASH 2025 this past week: the Phase 3 BRUIN-CLL 313 trial looking at Pirtobrutinib vs Bendamustine/Rituximab in 1L Chronic Lymphocytic Leukemia (CLL).

Back to Two Onc Docs · Report a problem